Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection

INTRODUCTION: Clostridium difficile infection (CDI) is a common cause of nosocomial diarrhea. Metronidazole and vancomycin are the primary treatment options for CDI, but increasing rates of antimicrobial resistance and severe, refractory disease have prompted the need for alternative agents. Tigecyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Britt, Nicholas S., Steed, Molly E., Potter, Emily M., Clough, Lisa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269622/
https://www.ncbi.nlm.nih.gov/pubmed/25466443
http://dx.doi.org/10.1007/s40121-014-0050-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269622/
https://www.ncbi.nlm.nih.gov/pubmed/25466443
http://dx.doi.org/10.1007/s40121-014-0050-x

Ejemplares similares